Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...

The Food and Drug Administration announced sweeping changes to its COVID-19 vaccine policy Tuesday, signaling a major ...

The requirement for placebo-controlled trials isn’t expected to affect the rollout this fall for older adults and other groups at high risk for severe illness.

The U.S. Food and Drug Administration approved Novavax's COVID-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The FDA's full approval of Nuvaxovid triggered a $175 million milestone payment to Novavax from Sanofi, related to their ...

A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...

A landmark study by scientists at the University of Oxford, has unveiled crucial insights into the way that COVID-19 vaccines mitigate severe illness in those who have been vaccinated.

Overweight and obesity were significantly associated with memory issues and persistent headache, among other conditions.

More public events coming: Makary disclosed plans to hold public roundtables on cosmetics and drug regulation issues ... rethink the science around Covid vaccine efficacy now that the virus ...